Status:
TERMINATED
REEDUCATION OF OLFACTORY DISORDERS AFTER A CEREBRAL VASCULAR ACCIDENT IN ADULTS
Lead Sponsor:
University Hospital, Caen
Conditions:
Adult With Stroke and Olfaction's Complaint
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Study context: The literature identifies more and more research revealing olfactory disorders, with a high frequency after an acquired brain injury. So far, studies have mainly focused on post-trauma...
Eligibility Criteria
Inclusion
- Adult patient under 65 in order to avoid presbyosmia bias,
- Patient suffering from an ischemic and / or hemorrhagic stroke dating at least 3 months,
- Patient followed in the SRH department and / or in post-stroke consultation,
- French-speaking patient,
- Patient affiliated to the social security scheme,
- Patient having signed the informed consent.
Exclusion
- Patient with a TDI score greater than 30.5 on the SST,
- Patient with global aphasia: score \<25 on the oral comprehension subtest of MT86 sentences (1),
- Person under legal protection (guardianship, curatorship, safeguard of justice),
- Patient treated with corticosteroids, corticosteroids, steroids, antihistamines and antibiotics which may have repercussions on olfaction,
- History of trauma to the face,
- History of ENT surgery,
- Chronic rhinitis,
- Infection of the ENT sphere in the 15 days preceding inclusion,
- Neurodegenerative pathology,
- Parosmia, phantosmia or cacosmia,
- History of systemic chemotherapy or radiotherapy to the head.
Key Trial Info
Start Date :
January 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 16 2022
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04703218
Start Date
January 11 2022
End Date
November 16 2022
Last Update
July 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Caen University Hospital
Caen, France